Nearly 30% of clear cell renal cell carcinoma (ccRCC) patients present with metastasis at the time of diagnosis, and the prognosis for these patients is poor. Therefore, novel potential prognostic biomarkers and therapeutic targets for ccRCC could be helpful. | An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma